146 related articles for article (PubMed ID: 15830509)
1. [Mesalazine is effective in Crohn disease 1].
Fallingborg J; Langholz E; Christensen LA; Munkholm P; Dahlerup JF
Ugeskr Laeger; 2005 Mar; 167(11):1307-8; author reply 1309. PubMed ID: 15830509
[No Abstract] [Full Text] [Related]
2. [Mesalazine is effective in Crohn disease 2].
Quartarolo JP; Laegemidler F; Eskerod O
Ugeskr Laeger; 2005 Mar; 167(11):1308-9; author reply 1309. PubMed ID: 15830510
[No Abstract] [Full Text] [Related]
3. [Mesalazine is without clinical effect in patients with Crohn disease].
Munck LK
Ugeskr Laeger; 2005 Jan; 167(3):302-3. PubMed ID: 15704804
[No Abstract] [Full Text] [Related]
4. [Mesalazine is effective in Crohn disease].
Quartarolo JP
Ugeskr Laeger; 2005 Apr; 167(16):1767. PubMed ID: 15898611
[No Abstract] [Full Text] [Related]
5. Aminosalicylates for active disease and in the maintenance of remission in Crohn's disease.
Feagan BG
Eur J Surg; 1998 Dec; 164(12):903-9. PubMed ID: 10029385
[No Abstract] [Full Text] [Related]
6. [Mesalamine in the treatment of Crohn disease?].
Nielsen OH; Thomsen OO
Ugeskr Laeger; 2005 Apr; 167(15):1656-7. PubMed ID: 15892345
[No Abstract] [Full Text] [Related]
7. Mesalamine derivatives in the treatment of Crohn's disease.
Harrell LE; Hanauer SB
Gastroenterol Clin North Am; 2004 Jun; 33(2):303-17, ix-x. PubMed ID: 15177540
[TBL] [Abstract][Full Text] [Related]
8. [Angioedema in Crohn's disease possibly due to mesalazine].
Nguyen-Khac E; Le Baron F; Thevenot T; Tiry-Lescut C; Tiry F
Gastroenterol Clin Biol; 2002 May; 26(5):535-6. PubMed ID: 12122371
[No Abstract] [Full Text] [Related]
9. [Improved treatment of Crohn's disease].
Nau JY
Rev Med Suisse; 2005 May; 1(18):1241. PubMed ID: 15977716
[No Abstract] [Full Text] [Related]
10. [Drug therapy of Crohn disease].
Niemelä S
Duodecim; 2001; 117(8):807-14. PubMed ID: 12116446
[No Abstract] [Full Text] [Related]
11. Correction of mesalazine-induced neutropenia with high-dose G-CSF.
Bhidayasiri R; Katz JA; Sokos DR
Am J Gastroenterol; 2000 Nov; 95(11):3321-2. PubMed ID: 11095375
[No Abstract] [Full Text] [Related]
12. Mesalazine-induced aplastic anemia.
Wiesen A; Wiesen J; Limaye S; Kaushik N
Am J Gastroenterol; 2009 Apr; 104(4):1063. PubMed ID: 19259075
[No Abstract] [Full Text] [Related]
13. [Acute episode].
Schölmerich J;
Z Gastroenterol; 2003 Jan; 41(1):27-30. PubMed ID: 12541170
[No Abstract] [Full Text] [Related]
14. Mesalazine-induced lupus.
Timsit MA; Anglicheau D; Lioté F; Marteau P; Dryll A
Rev Rhum Engl Ed; 1997 Oct; 64(10):586-8. PubMed ID: 9385697
[TBL] [Abstract][Full Text] [Related]
15. The suspension of an announced trial on relapse prevention in Crohn's ileitis with a 5-ASA formulation in microgranular form.
Prantera C; Bellinvia S
Dig Liver Dis; 2005 Feb; 37(2):135-6. PubMed ID: 15733528
[No Abstract] [Full Text] [Related]
16. [Paradigmatic shift in drug treatment of Crohn disease].
Munck LK
Ugeskr Laeger; 2005 Aug; 167(33):3013. PubMed ID: 16109239
[No Abstract] [Full Text] [Related]
17. Presentation of Crohn's disease as metastatic cutaneous non-caseating granulomatous lesions.
Delgado J; Delgado B; Sztarkier I; Cagnano E; Sperber AD; Fich A
Isr Med Assoc J; 2003 Dec; 5(12):897-8. PubMed ID: 14689766
[No Abstract] [Full Text] [Related]
18. [Maintenance effect of polyglycosides of Tripterygium wilfordii on remission in postoperative Crohn disease].
Tao QS; Ren JA; Ji ZL; Li JS; Wang XB; Jiang XH
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Sep; 12(5):491-3. PubMed ID: 19742342
[TBL] [Abstract][Full Text] [Related]
19. [Chronic inflammatory bowel diseases. Proven and innovative in the treatment].
MMW Fortschr Med; 2006 Jun; 148(24):43. PubMed ID: 16850809
[No Abstract] [Full Text] [Related]
20. Little benefit from mesalazine taken prophylactically after surgery for Crohn's disease.
Rutgeerts P
Gut; 2001 Apr; 48(4):452-3. PubMed ID: 11247886
[No Abstract] [Full Text] [Related]
[Next] [New Search]
